Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 24 November 2017. Database contains 337 unique substances/entries.
Filter the list

 
233-072-9
10028-22-5
2018
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
233-135-0
10043-01-3
2015
France
Suspected CMR
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
234-042-8
10508-09-5
2015
Italy
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
Wide dispersive use
Information requested
Details
234-126-4
10544-72-6
2019
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Not started
Details
236-476-3
13393-93-6
2019
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Not started
Details
236-675-5
13463-67-7
2018
France
CMR
Suspected Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Not started
Details
237-159-2
13674-87-8
2019
Germany
Potential endocrine disruptor
Not started
Details
237-695-7
13927-71-4
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Not started
Details
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Information requested
Details
241-527-8
17527-29-6
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Ongoing
Details
241-867-7
17928-28-8
2018
United Kingdom
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
242-016-2
18127-01-0
2019
Sweden
Suspected Reprotoxic
Not started
Details
242-060-2
127-91-3, 18172-67-3
2014
Greece
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
243-001-3
19372-44-2
2015
Germany
Sensitiser
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Ongoing
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
246-563-8
25013-16-5
2015
France
Consumer use
Exposure of sensitive populations
Potential endocrine disruptor
Suspected Reprotoxic
Wide dispersive use
Suspended
Details
246-677-8
25155-23-1
2014
Italy
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
246-678-3
25155-25-3
2015
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
246-835-6
25321-09-9
2019
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
247-118-0
25584-83-2
2019
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
247-156-8
25640-78-2
2018
Germany
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
247-426-5
26040-51-7
2019
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Not started
Details
247-660-8
26401-35-4
2013
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Follow-up
Details
247-722-4
26471-62-5
2012
Poland
CMR
Suspected PBT/vPvB
Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
247-759-6
26523-78-4
2013
France
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
248-227-6
27107-89-7
2019
Netherlands
Potential endocrine disruptor
Not started
Details
248-258-5
27138-31-4
2018
Latvia
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected Reprotoxic
Wide dispersive use
Not started
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
249-044-4
28472-97-1
2013
Italy
Consumer use
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
249-204-3
28768-32-3
2013
Denmark
CMR
Wide dispersive use
Follow-up
Details
249-535-3
29253-36-9
2019
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
250-610-8
31394-54-4
2012
Latvia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
251-020-3
32388-55-9
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Not started
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
253-057-0
36483-57-5
2019
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Not started
Details
253-249-4
36878-20-3
2018
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Not started
Details
253-775-4
38083-17-9
2014
United Kingdom
Suspected CMR
Consumer use
Wide dispersive use
Information requested
Details
253-781-7
38103-06-9
2013
Germany
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
254-052-6
38640-62-9
2013
Sweden
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Follow-up
Details
258-469-4
53306-54-0
2018
Germany
Potential endocrine disruptor
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Not started
Details
258-904-8
53988-10-6
2018
Germany
Potential endocrine disruptor
Exposure of environment
Not started
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
262-872-0
61617-00-3
2018
Germany
Potential endocrine disruptor
Exposure of environment
Not started
Details
262-975-0
61788-44-1
2014
United Kingdom
Cumulative exposure
Potential endocrine disruptor
Suspected PBT/vPvB
Information requested
Details
264-120-7
63393-96-4
2017
Italy
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Ongoing
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
266-042-9
65997-13-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Not started
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live2